People with breast cancer family history to be offered preventative ...

The draft published today is really important and one of the recommendations made is for the first time in U.K. women with a family history with breast cancer may be offered drugs to help prevent breast cancer. This is a really historic step. And it?s really important for people with a family history who have a much higher risk of developing breast cancer have a range of options available to put that risk under control.

From your charity?s point of view, which would be more important ? preventative drug or regular screening? Or both?

There?re different options people can take to control the risk. For example, they may be offered a more regular screening. Now we have an option that they could be offered drugs as a preventative. Other options available for women may be surgery to remove their breast to help them reduce the risk. Now, not each of these choices would be right for everybody, which is why it?s very important to have a whole range of options available so people can make their personal choices about how they can reduce the risk.

We?re talking about a very specific category of women in high risk and I think that applies to about 1% of women. That?d require quite a considerable testing and, in fact, testing on the genetic level, wouldn?t it?

It?s very important to note that most cases of breast cancer are not actually linked to family history of the disease. However, around 1 in 5 women who do develop breast cancer have a significant family history. And by family history we mean people who have an unusual high number of family members with breast cancer, often at young age. Most people don?t have a family history of breast cancer. If you?re at particularly high risk, you may be offered genetic testing. And the guideline to recommend today is that more people would be offered genetic testing, both for men and women.

So, are you confident that the findings and the consultations that the National Institute of Health and Clinical Excellence have launched will come in favor of tumors from being administered to women and men at high risk?

At the moment, these guidelines are draft, but we really hope that the recommendations will be passed. National Institute of Health and Clinical Excellence?s guidelines are based on the best possible evidence. And all that evidence was thoroughly considered.

Would there be concerns that some people could be misdiagnosed as being at high risk due to genetic factors and probably will be offered to take drugs that they don?t need?

If anybody does think that they?re at high risk of developing breast cancer, it?s very important that they go and talk about their family history with their doctor. There?re lots of important points to take into consideration. This will be very carefully studied by professionals. So it?s very unlikely that you will be told that you have a high risk of developing breast cancer, when you don?t. It?s also very important to remember that most people don?t have a family history of breast cancer and about 1 in 5 people who are diagnosed do have a significant risk. These guidelines are very important for these groups of people.

So you broadly welcome the consultation being launched today?

These guidelines represent a real historic step, particularly for the prevention of breast cancer. And even though most women don?t have a significant family history, it?s crucial that they have all options available to control that risk. These guidelines really give the opportunities. It?s really important.

Source: http://english.ruvr.ru/2013_01_16/People-with-breast-cancer-family-history-to-be-offered-preventative-options/

hangout todd haley kareem abdul jabbar miramonte elementary school mark jenkins super bowl commercials 2012 mia